Introduction {#s1}
============

VZV is a human pathogen that spreads to children as varicella or chicken pox and re-emerges later as zoster or shingles (Ross, [@B37]; Grose, [@B19]). VZV is one of nine human herpesviruses (Davison, [@B13]). The virus is supremely adapted to its human host and infects most people in a given community (Hope-Simpson, [@B23]; Choo et al., [@B12]). It is endemic throughout the world but largely controlled in some countries by vaccination with a live attenuated virus (Seward et al., [@B40]; Marin et al., [@B31]).

Varicella infection, within its natural human host, spreads from the nasopharynx via infection of a limited number of T cells that home to the skin epidermis (Arvin et al., [@B2]). Once there the infection is passed to the basal keratinocytes making up the innermost layer of the epidermis (Ku et al., [@B28]). The virus progressively infects other cells in its proximity until reaching the surface of the skin in the form of characteristic VZV vesicles. Within the area of the vesicle, polykaryocytes or multi-nucleated cells are found due to VZV-induced cell to cell fusion (Weigle and Grose, [@B46]). As the number of viral particles increase within the vesicle, some particles travel retrograde along sensory neurons in the skin to the sensory ganglia emanating from the spinal cord (Gilden et al., [@B17]). In the ganglia, the virus becomes latent or quiescent until much later (years or decades) in the life of the host. Under conditions of immunosuppression or aging, VZV can reactivate within the ganglia and spread back anterograde to the skin to cause zoster or shingles (Arvin, [@B1]). Typically, this event only happens from a single ganglion within one dermatome (Hope-Simpson, [@B23]).

VZV is an alphaherpesvirus that exists as a multilayered structure approximately 200 nm in diameter (Grose et al., [@B21]). In the virus particle, the genome (dsDNA) is surrounded by a protein capsid structure that is covered by an amorphous layer of tegument proteins. These two structures are surrounded by a lipid envelope that contains viral glycoproteins. The VZV genome is the smallest of the human herpesviruses and encodes at least 71 unique proteins (ORF0--ORF68) with three more opening reading frames (ORF69--ORF71) that duplicate earlier open reading frames (ORF64--62, respectively) (Davison and Scott, [@B14]). Only a fraction of the encoded proteins form the structure of the virus particle (Kinchington et al., [@B27]). Among those proteins are nine glycoproteins: ORF5 (gK), ORF9A (gN), ORF14 (gC), ORF31 (gB), ORF37 (gH), ORF50 (gM), ORF60 (gL), ORF67 (gI), and ORF68 (gE). Abundant biosynthesis of viral glycoproteins increases to the point of excluding cellular glycoprotein expression under conditions of infection in cultured cells (Grose, [@B18]).

Of importance, VZV induces autophagy in infected cells as well as exhibiting evidence of the Unfolded Protein Response (UPR): XBP1 splicing and a greatly expanded ER (Takahashi et al., [@B42]; Carpenter et al., [@B9]). More recently, we found that inhibition of autophagy by either 3-methyl adenine (3-MA) treatment or siRNA knockdown of ATG-5, a necessary autophagy protein, reduced glycoprotein expression and altered post-translational modifications of VZV gE and gI and ultimately VZV infectivity in culture. (Buckingham et al., [@B6]). These results highlight the role of VZV glycoprotein expression in inducing ER stress and associated autophagy. Our observations of enlarged ER and spliced XBP-1 in VZV infected cells led us to consider what other elements of the UPR are being activated. We decided to use a commercial PCR array that measures the levels of transcripts of 84 different components of the UPR. Herein we report the results of comparing VZV infected cells vs. tunicamycin treated cells with this UPR PCR array.

Methods {#s2}
=======

Viruses and cells
-----------------

VZV-32 is a low passage laboratory strain; its genome has been completely sequenced and falls within European clade 1 of VZV genotypes (Peters et al., [@B35]). MRC-5 human fibroblast cells or HeLa cells were grown in six well tissue culture plates with and without 12 mm round or 22 mm square coverslips in Minimum Essential Medium (MEM; Gibco, Life Technologies) supplemented with 7% fetal bovine serum (FBS), L-glutamine, non-essential amino acids, and penicillin/streptomycin. When monolayers were nearly confluent, MRC-5 cells were inoculated with VZV-infected cells at a ratio of one infected cell to eight uninfected cells by previously described methods (Grose and Brunel, [@B20]).

Transfection
------------

HeLa cells were transfected with plasmids containing VZV gE (pTargeT_gE) or VZV ORF62 (pCMV_IE62) under the CMV promoter as described previously (Carpenter et al., [@B9]). The plasmids were transfected into HeLa cells using ExtremeGene HP (Roche) transfection reagent (Jacobsen et al., [@B25]) at 10 μl/ml and plasmid DNA at a concentration of 1.0 μg/ml. After 6 h, the culture medium was replaced with plasmid/transfection reagent free medium. At 24 h post-transfection, RNA was extracted from all wells in a culture plate and cells incubated on coverslips were fixed and processed for microscopy.

Real-time RT-PCR
----------------

Total RNA was extracted from uninfected, tunicamycin treated and VZV infected fibroblast cells in six well plates at the given time points using the RNEasy mini kit (Qiagen). RNA quality and quantity was assayed by UV spectroscopy using a NanoDrop spectrometer. Both A260/A280 and A260/A230 ratios were within 20% of 2.0 and infected cells from a six well plate well (6.5 sq cm) yielded approximately 3 μg of RNA in 60 μl. Further, the RNA was electrophoresed in an Agilent Bioanalyzer 2100 (Agilent) and yielded RIN values within 20% of 10. Polyadenylated RNA was converted to cDNA using anchored Oligo(dT) primers and the SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen) to yield approximately 20 ng of cDNA. The entire cDNA sample from one well of cells was mixed into 1 ml of 1× diluted Power SYBR Green Master Mix (ABI) and split into all wells of a SA Biosciences UPR PCR array (Life Technologies) with a multichannel pipettor (25 μl per well). The measurements were carried out in triplicate using cDNA from three of the original six wells in the plate for all types of samples using a Model 7000 real time PCR instrument (ABI). The resulting PCR results were processed using the SDS 1.2.3 software (Applied Biosystems). C~T~ values of each measurement were normalized to an average of 16.0 for housekeeping genes (wells H1--H5 of the UPR array) to form ΔC~T~ values which were then used to calculate averages and standard deviations between triplicate measurements. Subsequent ΔΔC~T~ values were calculated by differences between averages of VZV infected ΔC~T~ values or tunicamycin treated ΔC~T~ values with the average uninfected ΔC~T~ values. Uncertainties correspond to propagation of errors using standard deviations between the uninfected and infected or tunicamycin averages.

RT-PCR primers
--------------

To confirm measurements from the UPR specific PCR array, several RT-PCR measurements were carried out using the following primers: BiP: forward 5′-CCC CAA CTG GTG AAG AGG AT-3′ and reverse 5′-GCA GTA AAC AGC CGC TTA GG-3′; DNAJB9/ERDj4: forward 5′-ACA TCT GTG ACT TGC GTT GC-3′ and reverse 5′-TGG GCA ATA AAA CCA TTT CC-3′; CREBH: forward 5′-GGG AGA CGA GCT GTG AGC-3′ and reverse 5′-TGT CTG AGT GTC GGT TCC TG-3′; PERK: forward 5′-GCC TAA GGA GGT AGC AGC AA-3′ and reverse 5′-GGG ACA AAA ATG GAG TCA GC-3′.

Antibodies
----------

Murine MAb antibodies to VZV gE (3B3) and IE62 (5C6) produced in our laboratory were used in addition to a rabbit polyclonal antibody to LC3B (Santa Cruz Biotech sc-28266).

Imaging protocols
-----------------

Samples of infected and uninfected cells were prepared for confocal microscopy by methods described previously (Carpenter et al., [@B8]). Briefly, the samples were fixed with paraformaldehyde and permabilized with 0.05% Triton-X-100 in PBS and then blocked in 5% non-fat milk with 2.5% normal goat serum for 2 h at RT. The primary antibody (1:2000) was added for 2 h at RT and overnight at 4°C. After washing (3 × 5 min with PBS) the samples were incubated with the secondary antibody (1:1250) and the Hoechst 33342 dsDNA stain (1:500) for 2 h at RT then washed before mounting on slides for viewing. Following preparation, the samples were viewed on a Zeiss 710 confocal fluorescent microscope (Duus et al., [@B15]).

Tunicamycin protocol
--------------------

Conditions for treatment of cultured cells with tunicamycin (2.5 μg/ml; Calbiochem, \#654380) have been described in earlier papers in which we were investigating VZV glycoprotein biosynthesis (Montalvo et al., [@B33]; Carpenter et al., [@B10]). For experiments in uninfected cells, tunicamycin (2.5 μg/ml) was added 24 h after subculturing and the monolayer was fixed after another 24 h.

ER labeling by dicarbocyanine dye
---------------------------------

DiOC~6~ (3-3-dihexyloxa-carbocyanine iodide) was obtained in powder form from Molecular Probes (D-273) and dissolved (0.7 mg/ml) in ethanol (Sabnis et al., [@B38]). An aliquot of the DiOC~6~ stock (2.8 μl/ml yielded a final concentration of DiOC~6~ of 2 μg/ml) was added to warm cell culture medium; this medium was applied to live cells for 30 min, then rinsed 2× with PBS and processed for fluorescent microscopy as described above.

Results {#s3}
=======

VZV infected cells exhibited abundant glycoprotein expression with an enlarged ER and increased autophagy
---------------------------------------------------------------------------------------------------------

Within cell culture, VZV is entirely cell associated with no release of cell-free virus (Grose and Brunel, [@B20]; Weller, [@B47]). Monolayers are inoculated with VZV-infected cells. The susceptibly of cells to VZV determines how long it takes to infect the whole monolayer but spread typically requires 3--5 days. Within infected cell monolayers, we observe a range of fused cells. For example, VZV induces massive syncytia involving hundreds of nuclei in melanoma cells while VZV infection of less fusogenic cells such as lung fibroblasts or skin keratinocytes induces syncytia involving tens of nuclei.

Recently, we observed that VZV induces increased LC3-positive puncta formation indicative of autophagosomes within cultured cells as well as from cells removed from varicella and zoster vesicles (e.g., Figures [1A1,A2](#F1){ref-type="fig"}) (Takahashi et al., [@B42]). Unlike the closely related herpes simplex virus, VZV does not encode any known inhibitors of autophagy, such as ICP 34.5. Later we observed that VZV infected cells also exhibited signs of ER stress, namely *XBP-1* splicing and a greatly enlarged ER (see, e.g., Figures [1B1,B2](#F1){ref-type="fig"}). The latter results led to the hypothesis that VZV glycoprotein synthesis induces ER stress that is partially relieved by an enlarging ER and increased autophagy (Carpenter et al., [@B9]).

![**VZV infected cells exhibited abundant glycoprotein expression, increased autophagosomes, and an enlarged ER**. Human fibroblast cells (MRC-5) were grown on glass coverslips in tissue culture plates until 60% confluent and then infected with VZV-32 infected MRC-5 cells at a ratio of 1:8. At 48 hpi, the cultures were fixed, permeabilized, blocked and immunolabeled for VZV gE, IE62, or cellular LC3B. The cells were then imaged at 400× with a Zeiss 710 confocal fluorescence microscope. Other cultures grown and infected similarly were incubated in medium containing DiOC6, a polar dye, prior to fixation. **(A1)** VZV glycoprotein gE expression is abundant in three cells (solid arrows) in the image. **(A2)** LC3 puncta indicative of autophagosomes are apparent in cells expressing gE (arrows, dashed line) and nearby cells that are newly infected (arrows, solid line). **(B1)** DiOC~6~ staining in 19 cells at 630×. A representative white ellipse indicates the enlarged ER in an infected syncytium. **(B2)** VZV IE62 staining indicates that all 19 cells are infected and several are in syncytia.](fmicb-05-00322-g0001){#F1}

UPR gene transcription was different in VZV infected cells vs. tunicamycin treated cells
----------------------------------------------------------------------------------------

Based on the observations in the previous section, we sought to further document the induction of the UPR within VZV infected cells via a UPR-specific PCR array manufactured by SA Biosciences (now part of Qiagen). This 96 well plate consists of 84 wells containing primers to the 3′ Untranslated Region (UTR) of transcripts associated with the UPR and the remaining 12 wells containing primers to housekeeping genes and PCR and cDNA quality control wells. Table [1](#T1){ref-type="table"} lists the UPR specific primers or wells where the wells are grouped by association with a given UPR function: ANTI or PRO (anti or pro-apoptotic), ERAD (ER associated degradation), FOLD (primarily folding chaperones), LIPID (transcripts associated with lipid synthesis and metabolism), SENSOR (transcripts associated with ER membrane resident proteins known to "sense" and signal ER stress conditions), TF (other transcription factors like C/EBPβ) and finally TRANS for two components associated with protein translation. Each group will be described more fully in the next sections.

###### 

**UPR qPCR results for tunicamycin treated and VZV infected cells**.

  **Gene**            **Function**                                                                  **Group**   **TM treated**   **VZV infected**          
  ------------------- ----------------------------------------------------------------------------- ----------- ---------------- ------------------ ------ -----
  ARMET/MANF          ERSE-II regulated; reduces cell proliferation and UPR initiated apoptosis     ANTI        5.0              0.2                6.1    0.5
  EDEM3               ER degradation enhancer, mannosidase alpha-like 3                             ERAD        −1.5             0.9                −4.7   0.9
  PPIA                Peptidylpropyl isomerase A (cyclophilin A)                                    ERAD        −1.4             0.2                −0.7   0.5
  UBE2G2              E2 ubiquitin conjugating enzyme G2                                            ERAD        −0.9             0.2                0.4    0.5
  NPLOC4 (NPL4)       Regulates poly Ub on cytosolic side of ER membrane with VCP                   ERAD        −0.7             0.2                1.9    0.5
  UBXN4/erasin        UBX domain protein 4---adaptor protein to VCP                                 ERAD        −0.5             0.3                −6.1   0.5
  USP14               Ubiquitin specific peptidase 14 in cytosol                                    ERAD        −0.4             0.3                −0.3   0.5
  SEC62               ERAD translocation pore formation                                             ERAD        −0.2             0.3                −4.3   0.4
  UFD1L               Regulates poly Ub on cytosolic side of ER membrane with VCP                   ERAD        0.1              0.1                0.9    0.4
  UBE2J2              E2 ubiquitin conjugating enzyme J2                                            ERAD        0.2              0.1                −0.4   0.4
  ATXN3               Ataxin 3---deubiquiting enzyme                                                ERAD        0.8              0.2                3.8    0.5
  FBX06               E3 ubiquition ligase of glycoproteins in ER lumen                             ERAD        0.9              0.1                −2.1   0.4
  RNF5                Ring Finger protein 5---E3 Ubiquitin ligase in ER membrane                    ERAD        1.1              0.1                1.1    0.4
  DERL1               Derlin family member E3 Ubiquitin ligase in ER membrane                       ERAD        1.2              0.2                2.0    0.5
  VCP(p97)            Regulates poly Ub of translocated ER substrates with NPL4 and UFD1L           ERAD        1.3              0.2                −0.4   0.5
  EDEM1               ER degradation enhancer, mannosidase alpha-like 1---trims mannose             ERAD        1.4              0.2                1.5    0.4
  SEL1L               Adaptor protein of Derlin-3/HRD1 in ER membrane                               ERAD        2.0              0.3                −2.6   0.4
  OS9                 Glycoprotein protein quality control                                          ERAD        2.0              0.2                −0.7   0.5
  DERL2               Derlin family member, E3 Ubiquitin ligase in ER membrane                      ERAD        2.4              0.2                −1.3   0.5
  SYVN1 (DER3/HRD1)   Synoviolin, Derlin family member E3 Ubiquitin ligase in ER membrane           ERAD        2.7              0.1                1.9    0.4
  SELS                Selenoprotein S---oxidoreductase (oxidative stress)                           ERAD        3.0              0.2                1.6    0.5
  HERPUD1 (HERP)      Mediates degradation of ER Ca channels                                        ERAD        4.3              0.3                −1.9   0.5
  HSPA2               HSP70 protein 2                                                               FOLD        −1.5             0.3                1.2    0.6
  HSPA4               HSP70 protein 4                                                               FOLD        −0.8             0.3                1.4    0.5
  HSPA1B              HSP70 protein 1B                                                              FOLD        −0.5             0.2                0.0    0.5
  GANAB (Glu II)      Glucosidase that trims N-linked glycans                                       FOLD        −0.5             0.3                −1.6   0.5
  PRKCSH              Protein kinase C substrate 80K-H (subunit of glucosidase II)                  FOLD        −0.4             0.2                1.7    0.5
  GANC                Glycosal hydoloysis                                                           FOLD        −0.2             0.2                2.3    0.4
  TCP1                Component of Chaperonin                                                       FOLD        −0.2             0.1                −0.7   0.4
  HSPA1L              HSP70 protein 1 like                                                          FOLD        −0.1             0.2                −3.0   0.4
  HSPA4L              HSP70 protein 4 like                                                          FOLD        0.0              0.3                −1.7   0.5
  CCT4                Chaperonin containing TCP1, subunit 4 (delta)                                 FOLD        0.3              0.1                −1.3   0.4
  CCT7                Chaperonin containing TCP1, subunit 7 (eta)                                   FOLD        0.4              0.2                0.4    0.5
  HSPH1               HSP105 protein 1                                                              FOLD        0.6              0.1                1.6    0.4
  PFDN5               Prefoldin subunit 5; co-chaperone of Chaperonin complex                       FOLD        0.7              0.2                2.2    0.5
  PFDN2               Prefoldin subunit 2                                                           FOLD        1.0              0.2                1.5    0.5
  TOR1A               Torsion A---ATPase                                                            FOLD        1.0              0.2                −1.0   0.5
  UGCGL2 (UGT2)       UDP-glucose ceramide glucosyltransferase-like 2                               FOLD        1.0              0.2                1.6    0.5
  UGCGL1 (UGT1)       UDP-glucose ceramide glucosyltransferase-like 1                               FOLD        1.1              0.2                0.9    0.5
  ERP44               Thiol chaperone                                                               FOLD        1.5              0.3                −1.8   0.5
  CALR                Calreticulin; glycoprotein folding chaperone                                  FOLD        1.5              0.3                −1.1   0.5
  RPN1                Ribophorin 1---substrate specific facilitator of N-glycosylation              FOLD        1.6              0.2                −1.6   0.5
  ERO1L               Thiol oxidase governs redox state of ER (with Ca2+)                           FOLD        1.6              0.3                0.8    0.5
  DNAJC10 (ERdj5)     DNAJ (HSP40 homolog), subfamily C, member 10                                  FOLD        1.7              0.3                −1.0   0.5
  DNAJB2              DNAJ (HSP40 homolog), subfamily B, member 2                                   FOLD        1.8              0.2                2.0    0.5
  SEC63               Regulates ER import of membrane proteins                                      FOLD        2.1              0.2                0.3    0.4
  CANX                Calnexin; glycoprotein folding chaperone; binds Ca2+                          FOLD        2.2              0.3                1.2    0.5
  SIL1(BAP)           Nucleotide exchange factor; binds BiP                                         FOLD        2.4              0.1                2.0    0.4
  PDIA3 (ERP57)       Protein disulfide isomerase family A, member 3                                FOLD        2.5              0.3                1.9    0.5
  DNAJC3              DNAJ (HSP40 homolog), subfamily C, member 3                                   FOLD        2.6              0.1                2.4    0.4
  DNAJC4              DNAJ (HSP40 homolog), subfamily C, member 4                                   FOLD        2.9              0.2                2.9    0.5
  ERO1LB              Thiol oxidase governs redox state of ER (with Ca2+)                           FOLD        3.8              0.2                1.5    0.4
  DNAJB9 (ERdj4)      DNAJ (HSP40 homolog), subfamily B, member 9                                   FOLD        5.5              0.2                −2.9   0.5
  HSPA5               HSP70 protein 5 GRP78 (BIP)                                                   FOLD        6.3              0.1                4.7    0.4
  SREBF2              Sterol regulatory element binding TF 2                                        LIPID       0.9              0.1                −1.9   0.4
  RNF139 (TRC8)       E3 Ubiquition ligase associated with INSIG                                    LIPID       −0.3             0.6                −1.2   0.6
  INSIG2              Insulin induced protein isoform 2; regulation of cholesterol synthesis        LIPID       0.3              0.3                4.1    0.4
  INSIG1              Insulin induced protein isoform 1; regulation of cholesterol synthesis        LIPID       0.5              0.3                5.3    0.4
  AMFR (gp78)         Autocrine motility factor receptor; E3 Ub ligase; regulation of cholesterol   LIPID       0.6              0.3                6.2    0.5
  SREBF1              Sterol regulatory element binding TF 1                                        LIPID       1.1              0.2                0.3    0.5
  SCAP                Activates SREBF by cleaving it                                                LIPID       1.6              0.2                −0.3   0.5
  SERP1 (RAMP4)       Stress induced ER protein 1; ER salt channel regulation                       LIPID       2.7              0.3                2.9    0.6
  MAPK8 (JNK1)        Map kinase K8 aka JNK1; pro-apoptotic in response to TNFα                     PRO         −0.8             0.1                2.2    0.4
  BAX                 BCL2-associated X protein; induces release of COX-2 from mitochondria         PRO         0.5              0.3                −1.0   0.5
  MAPK9 (JNK2)        Mitogen-activated protein kinase 9                                            PRO         0.5              0.2                1.0    0.4
  HTRA2               HTRA serine peptidase 4                                                       PRO         0.6              0.2                −0.2   0.5
  MAPK10 (JNK3)       Map kinase K10 aka JNK3; pro-apoptotic in neurons                             PRO         1.0              0.4                2.3    0.6
  HTRA4               HTRA serine peptidase 2                                                       PRO         1.4              0.4                4.0    0.6
  CHOP                Aka DDIT3/GADD153; ER stress associated apoptotic protein                     PRO         5.3              0.2                0.1    0.4
  MBTPS2/S2P          Membrane bound TF peptidase, site 2 (active in Golgi)                         SENSOR      −0.2             0.3                1.0    0.4
  MBTPS1/S1P          Membrane bound TP peptidase, site 1 (active in Golgi; cleaves ATF6)           SENSOR      −0.1             0.2                0.1    0.4
  ERN1 (IRE1α)        IRE1α is an endonuclease that splices XBP1 upon activation                    SENSOR      0.0              0.2                1.6    0.4
  ATF6B               ATF6 beta                                                                     SENSOR      0.5              0.3                −3.0   0.5
  CREB3 (LUMAN)       OASIS (B-zip TF) family member; cell proliferation                            SENSOR      1.4              0.2                1.0    0.4
  ATF6                Activating transcription factor 6                                             SENSOR      1.5              0.2                0.3    0.5
  EIF2AK3 (PERK)      ER stress sensor; PKR-like kinase                                             SENSOR      1.6              0.2                −4.2   0.5
  ERN2 (IRE1β)        ER to nucleus signaling protein 2                                             SENSOR      1.8              0.5                3.1    0.6
  NUCB1               Nucleobindin 1; negative regulation of ATF6                                   SENSOR      3.1              0.2                4.1    0.5
  CREB3L3 (CREBH)     TF regulating lipogenesis and secretory pathway                               SENSOR      4.4              1.6                9.3    0.9
  XBP1                X box binding protein 1; splicing by IRE1 activates XBP1                      TF          0.7              0.1                −0.4   0.4
  CEBPB (C/EBPβ)      Bzip TF with wide impact on cell cycle and proliferation                      TF          1.3              0.3                −2.9   0.6
  ATF4                Activates stress response (including CHOP)                                    TF          1.7              0.2                1.5    0.5
  EIF2A               Eukaryotic translation initiation factor 2A                                   TRANS       0.0              0.5                0.1    0.4
  PPP1R15A            Protein phosphatase 1, subunit 15A                                            TRANS       1.8              0.2                1.1    0.4

Human fibroblast cells (MRC-5) were grown on glass coverslips in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was extracted from the VZV-32 infected cultures. For the TM treated cultures, RNA was extracted at 24 h post-treatment. RNA from the VZV-32 infected, TM treated and uninfected cell cultures was then converted to cDNA which was applied to UPR specific PCR arrays (SA Biosciences) and real time PCR was carried out on an ABI 7000 PCR instrument The resulting CT values were then normalized (ΔC~T~) by housekeeping genes in the plate and then differences (ΔΔC~T~) between the uninfected and infected or tunicamycin treated values were computed and averaged. Abbreviations: anti-apoptotic (ANTI), ER associated degradation (ERAD), protein folding chaperones (FOLD), lipid and fat metabolism (LIPID), pro-apoptotic (PRO), ER stress sensor proteins (SENSOR), other transcription factors (TF) and protein translation associated proteins (TRANS). Error estimates correspond to standard deviation (STD).

Gene transcripts were measured in uninfected human fibroblasts, tunicamycin (TM) treated fibroblasts and VZV infected fibroblasts. Each measurement was done in triplicate. The measured C~T~ values were normalized so that in each case the housekeeping gene transcripts measured C~T~ average was 16 and then the triplicate measurements were averaged and standard deviations computed to generate ΔC~T~. Differences between the uninfected ΔC~T~ and those associated with TM treated and VZV infected cell transcript measurements were then calculated to form the final measurements ΔΔC~T~ listed in Table [1](#T1){ref-type="table"}. Graphs of the resulting values (Figure [2](#F2){ref-type="fig"}) showed that tunicamycin treatment, a classical ER stressor by inhibition of N glycosylation, upregulated 66 of the 84 UPR genes, with known folding chaperones, e.g., BiP (in blue), particularly upregulated. Also upregulated is the pro-apoptotic factor *CHOP* (pink). By contrast, only 43 of the UPR genes are upregulated in VZV infected cells. In particular, those genes most upregulated such as *CREB3L3/CREBH* (light blue) are more upregulated than after TM treatment. VZV infected cells also upregulated the LIPID transcripts *AMFR/gp78* and *INSIG* (green) while downregulating a number of ERAD components such as *UBXN4/erasin* and *EDEM3* (red). These differences will be considered by group in the subsequent sections.

![**UPR gene transcription was significantly different in VZV infected cells vs. either uninfected cells or tunicamycin treated cells**. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was extracted from the VZV-32 infected cultures. For the TM treated cultures, RNA was extracted at 24 h post-treatment. RNA from the VZV-32 infected, TM treated and uninfected cell cultures was then converted to cDNA, which was applied to UPR specific PCR arrays (SA Biosciences); real time PCR was carried out on an ABI 7000 PCR instrument. The resulting C~T~ values were then normalized (ΔC~T~) by the housekeeping genes of the plate and differences (ΔΔC~T~) between the uninfected and infected or tunicamycin treated values were computed and averaged. Graphs of the resulting values show that tunicamycin treatment, a classical ER stressor, resulted in upregulation of 66 of the 84 UPR genes with known folding chaperones such as *BiP* (in blue). Also upregulated was the pro-apoptotic factor *CHOP*. By contrast, only 43 of the UPR genes were upregulated in VZV infected cells although several, such as *CREBH*, were more upregulated than in tunicamycin treated samples. Error bars correspond to standard deviation when averaging.](fmicb-05-00322-g0002){#F2}

VZV infection significantly upregulated the transcription factor CREBH
----------------------------------------------------------------------

The SENSOR grouping includes the best known ER stress sensors: *PERK, IRE1α* and *ATF6* but also two CREB proteins (*CREB3/LUMAN* and *CREBH*) as well as primers to the Golgi resident proteases *S1P* and *S2P* that activate AT6 and the CREB proteins by cleavage (Ye et al., [@B49]; Asada et al., [@B3]). Included in the group are lesser known transcripts including *IRE1β, ATF6β*, and *NUCB1*.

CREBH, the cAMP responsive element binding protein H, is an ER anchored transcription factor implicated in nutrient metabolism and the proinflammatory response. VZV infected cells displayed more transcripts of *CREBH* and fewer of *ATF6β* and *PERK* (all with *p* \< 0.001) than in TM treated cells (Figure [3A](#F3){ref-type="fig"}). TM treatment generally upregulated all ER sensor transcripts with *CREBH* the most upregulated. *CREBH* transcription has previously been described as upregulated in hepatocytes and has been associated with lipid synthesis and acute phase transcription in T-cells (Zhang et al., [@B52], [@B51]). More recently, CREBH as a transcription factor has been described as increasing the capacity of the secretory pathway (Barbosa et al., [@B5]). *ATF6β* and *ATF6α* share similar structures but differ in function. In particular, *ATF6β* has been reported to inhibit transcription of *ATF6α* one of the primary ER stress sensors (Thuerauf et al., [@B44]).

![**VZV infection significantly upregulated the transcription factor *CREBH***. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was processed as described in legend to Figure [2](#F2){ref-type="fig"}. All gene transcription measurements were graphed for tunicamycin treated and VZV infected cell samples. **(A)** By measurements using the UPR specific PCR array, VZV infected cells showed significant upregulation of *CREBH* with downregulation of *PERK* and *ATF6β*. Tunicamycin treatment upregulated to a lesser extent all stress SENSORs. **(B)** To assess some of the measurements by the UPR array, cDNA from VZV infected and tunicamycin treated cells was submitted for real-time (RT-) PCR using primers specific to *CREBH* and *PERK* (see Methods section for primer information). Error bars correspond to standard deviation when averaging.](fmicb-05-00322-g0003){#F3}

In order to confirm the results of the UPR specific PCR array, we carried out qPCR measurements using primers to *CREBH* and *PERK* (Figure [3B](#F3){ref-type="fig"}) in TM treated cells and at several timepoints in VZV infected cells. Those measurements confirm the upregulation of *CREBH* by TM treatment but particularly in VZV infected cells (*p* \< 0.01). However, the downregulation of *PERK* in VZV infected cells was not confirmed.

VZV infected cells exhibited uneven fold gene transcription
-----------------------------------------------------------

Within the FOLD group, the largest, there are 32 wells with primers to eight HSP-70 homologs including *HSPA5/BiP* and *SIL1/BaP*; five DNAJ HSP-40 homologs including *DNAJB9/ERdj4* and *DNAJC10/ERdj5*; twelve wells contain primers to transcripts encoding ER lumen folding components including *CALR* and *CANX*; three components of the folding chaperonin complex and finally four components in the ER membrane including *RPN1* and *SEC63*. Many of these transcripts encode proteins which assist secretory protein folding but also sense misfolded proteins in the ER (Schroder, [@B39]). For example, DNAJC10/ERdj5 is a disulfide reductase that associates with ERAD component EDEM (Hagiwara et al., [@B22]).

VZV infected cells exhibited very uneven transcription of folding chaperones (FOLD) while TM treatment robustly upregulated transcription of these chaperones particularly *BiP* (Figure [4A](#F4){ref-type="fig"}). Measurements with the UPR specific PCR array showed VZV infected cells upregulated *BiP* while downregulating *DNAJB9/ERdj4* and *HSPA1L*. In order to reassess these observations, we carried out qPCR measurements of *BiP* and *DNAJB9/ERDj4* using primers specific to those transcripts (Figure [4B](#F4){ref-type="fig"}) and found that neither the upregulation of *BiP* nor downregulation of *DNAJB9/ERDj4* was confirmed. Rather the qPCR results found *BiP* to be moderately downregulated as the infection progressed to more cells (*p* \< 0.05). However, we also reassessed the regulation of the ER-co-chaperone DNAJC10/ERdj5 and found a correlation with the UPR-specific array (data not shown).

![**VZV infected cells exhibited uneven transcription of protein folding genes**. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was processed as described in legend to Figure [2](#F2){ref-type="fig"}. All gene transcription measurements were graphed for tunicamycin treated and VZV infected cell samples. **(A)** Using the UPR specific PCR array, tunicamycin treated cells exhibited significant upregulation of transcripts of FOLD chaperones while VZV infected cells exhibited a much more uneven pattern of up or down regulation of FOLD transcripts. In particular, *ERdj4/DNAJB9* and *HSPA1L* were downregulated with only *BiP* showing upregulation. **(B)** To assess some of the measurements by the UPR array, cDNA from VZV infected and tunicamycin treated cells was submitted for real-time (RT-) PCR, using primers specific to *BiP* and *ERdj4/DNAJB9* (see Methods section for primer information). Error bars correspond to standard deviation when averaging.](fmicb-05-00322-g0004){#F4}

VZV infected cells significantly downregulated ERAD gene transcription
----------------------------------------------------------------------

There are 21 ERAD associated wells that amplify a number of known transcripts that code for proteins that are involved in the degradation of misfolded proteins in the ER through a number of steps: recognition of misfolding (*OS9, PPIA* and *SELS* along with a number of FOLD transcripts), trimming of mannose residues prior to recognition by E3 ubiquitin ligases (*EDEM1* and *EDEM3*), recognition of misfolded proteins by E3 ubiquition ligases (*DERL3/HRD1, DERL2, DERL1, HERP, RNF5*, and associated factors *SEL1L* and *FBX06*), exportation to the cytosolic side of the ER membrane (*SEC62*) where the VCP/p97 complex poly-ubiquitinates protein substrates before extracting/clipping the protein from the membrane to be ultimately degraded in the cytosol by the proteasome (Schroder, [@B39]; Merulla et al., [@B32]). The *VCP/p97* complex includes its cofactors *UFD1L* and *NPLOC4* and regulators *ATAXIN3* and *ARMET/erasin* as well as the E2 ubiquitin-conjugators *UBE2J2* and *UBE2G2* (Ballar et al., [@B4]). Finally, there is a cytosolic protease, *USP14*, included in this grouping.

While TM treatment showed almost complete upregulation of ERAD transcripts particularly *HERP* (Figure [5A](#F5){ref-type="fig"}), VZV infection showed considerable downregulation of ERAD transcript (Figure [5A](#F5){ref-type="fig"}) where *EDEM3, UBXN4/erasin* and *SEC62* were downregulated. However, *ATAXIN3* was upregulated in VZV infected cells. Both erasin and ATAXIN3 are regulators, positive and negative, respectively, of VCP/p97 (Lim et al., [@B29]; Liu and Ye, [@B30]). As noted above, VCP/p97 forms the protein complex in the ER membrane on the cytosolic side that poly-ubiqininates ERAD substrates that are then released into the cytosol to be degraded by the proteasome (Ballar et al., [@B4]). Downregulation of VCP/p97 via its regulators appeared to reduce ERAD in VZV infected cells. All observed differences were significant with *p* \< 0.001. Again, in order to reassess two of the more striking observations from the UPR specific PCR array, we carried out qPCR measurements using primers to *UBXN4/erasin* and *ATAXIN-3* (Figure [5B](#F5){ref-type="fig"}). These measurements showed *UBXN4/erasin* to be modestly downregulated in VZV infected cells while ATAXIN-3 was essentially unchanged.

![**VZV infection moderately downregulated ER associated degradation genes**. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was processed as described in the legend to Figure [2](#F2){ref-type="fig"}. All gene transcription measurements were graphed for tunicamycin treated and VZV infected cell samples. **(A)** By measurements using the UPR specific PCR array, VZV infected cells showed significant downregulation of several elements of the ERAD pathway: *EDEM3, ERASIN*, and *SEC62*. Tunicamycin treatment, in contrast, upregulated most of the ERAD transcripts. **(B)** In order to assess two of the ERAD transcript measurements by the UPR specific PCR array, RT-PCR was carried out on cDNA from uninfected, tunicamycin treated and VZV infected cells, using primers to *UBXN4/erasin* and *ataxin-3.*](fmicb-05-00322-g0005){#F5}

VZV infected cells upregulated transcription of cholesterol synthesis regulator INSIG
-------------------------------------------------------------------------------------

Transcripts associated with lipid synthesis and metabolism such as *RAMP4* showed similar transcription in both VZV infected and TM treated cells but VZV infected cells, in particular, showed increased transcription of cholesterol synthesis regulators *AMFR/gp78* and *INSIG* (Figure [6A](#F6){ref-type="fig"}). *AMFR/gp78* is an E3 ubiquitin ligase and INSIG is an insulin signaling factor (Flury et al., [@B16]; Chen et al., [@B11]). Both are localized to the ER membrane and when activated function together to degrade HMG COA reductase, a cholesterol synthesis enzyme (Jo et al., [@B26]; Tsai et al., [@B45]).

![**VZV infection significantly upregulated the cholesterol synthesis associated transcript *INSIG***. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was processed as described in the legend to Figure [2](#F2){ref-type="fig"}. **(A)** Transcripts associated with lipid synthesis and metabolism where both VZV infected cells and tunicamycin cells showed similar transcription of *RAMP4;* VZV infected cells in particular showed more transcription of cholesterol synthesis regulator *INSIG*. **(B)** In order to assess two of the lipid transcript measurements by the UPR specific PCR array, RT-PCR was carried out on cDNA from uninfected, tunicamycin treated and VZV infected cells using primers to *AMFR/gp78* and *INSIG1.*](fmicb-05-00322-g0006){#F6}

In order to reassess the upregulation of *AMFR/gp78* and *INSIG*, we carried out qPCR measurements using primers to each transcript (Figure [6B](#F6){ref-type="fig"}). Of note, *INSIG* was upregulated in VZV infected cells at early timepoints in agreement with the UPR specific array, while *AMFR/gp78* was not increased. Of note, greater transcription of *INSIG* may lead to reduced cholesterol synthesis in VZV infected cells with the consequence of a more fluid ER in those cells. Cholesterol acts as a stabilizing agent in lipid membranes by supporting adjacent lipid head groups and reducing disorder of the lipid hydrocarbon chains internal to the bilayer (Mouritsen and Zuckermann, [@B34]). All observed differences were significant with *p* \< 0.001.

VZV infected cells downregulated the transcription factor *C/EBPb* and displayed differential transcription of apoptotic transcripts
------------------------------------------------------------------------------------------------------------------------------------

Transcription of cellular transcription factor *C/EBPβ* was significantly downregulated (*p* \< 0.001) in VZV infected cells as compared to the value in TM treated cells (Figure [7A](#F7){ref-type="fig"}) C/EBPβ is a transcription factor with a large effect on cellular proliferation (Tang and Lane, [@B43]). Downregulation of this factor may put VZV infected cells into a non-proliferative state. Transcription of apoptotic genes differed considerably between VZV infected cells and TM treated cells. TM treated cells exhibited much higher *CHOP* transcription than VZV infected cells while VZV infected cells showed a greater number of transcripts associated with cellular apoptosis such as *HTRA4* and the MAP kinases *JNK1* and *JNK3* (Figure [7B](#F7){ref-type="fig"}). Finally there was no difference between the levels of two protein translation associated transcripts in VZV infected cells vs. TM treated cells (Figure [7C](#F7){ref-type="fig"}).

![**VZV infection downregulated the transcription factor *C/EBPb* and displayed differential transcription of apoptotic transcripts**. Human fibroblast cells (MRC-5) were grown in tissue culture plates then infected with VZV-32 infected MRC-5 cells or treated with tunicamycin (TM), a N-glycosylation inhibitor. At 72 hpi, RNA was processed as described in the legend to Figure [2](#F2){ref-type="fig"}. **(A)** Transcription of apoptotic genes differed considerately between VZV infected cells and tunicamycin treated cells. VZV infected cell transcripts showed very fewer *CHOP* transcripts when compared to TM treatment; infected cells had more transcripts associated with cellular apoptosis such as *HTRA4* and MAP kinases *JNK1* and *JNK3*. **(B)** Transcription of cellular transcription factor *C/EBPβ* was significantly downregulated in VZV infected cells as compared to the value in TM treated cells **(C)**. There was no difference between VZV vs. TM treatment for two protein translation associated transcripts. Error bars correspond to standard deviation when averaging.](fmicb-05-00322-g0007){#F7}

Transfection of VZV gE upregulated transcription of *CREBH* and *BiP* while transfection of VZV IE62 did not
------------------------------------------------------------------------------------------------------------

In 2011, we found that transfecting cells with VZV glycoprotein genes led to increased autophagosome production and inflation of the ER. Transfection with VZV IE62 led to neither increased autophagosomes nor a larger ER. Therefore, we measured by qPCR whether CREBH and BiP transcription was increased by transfection of a glycoprotein vs. a non-glycoprotein that is also the major transactivator encoded by VZV. Transfection with a plasmid encoding VZV gE under the CMV immediate early promoter led to approximately 10% of transfected cells (Figure [8A1](#F8){ref-type="fig"}) while transfection with VZV IE62 also under the CMV immediate early promoter led to a larger number, approximately 40%, of transfected cells (Figure [8A2](#F8){ref-type="fig"}). Even though a low fraction of cells were transfected with VZV gE, increased transcription of *CREBH* and *BiP* were observed in those cells (Figures [8B1,B2](#F8){ref-type="fig"}) whereas not in cells transfected with VZV IE62 even though many more cells were transfected in those samples (*p* \< 0.01). We therefore conclude that expression of a single VZV glycoprotein gene in cells is sufficient to activate the CREBH arm of the UPR.

![**CREBH and BiP transcription were upregulated in cells transfected with VZV gE but not VZV IE62**. HeLa cells were grown in six well culture plates with or without glass coverslips and subsequently transfected with plasmids encoding the VZV gE glycoprotein or a non-glycosylated VZV IE62 protein, using either Lipofectamine 2000 or ExtremeGene HP transfection reagents. 6 h after the transfection reagent and plasmid were applied to the cells, the medium was replaced with fresh medium. Some monolayers were processed for microscopy while others were harvested for RNA extraction. The extracted RNA was converted to cDNA and RT-PCR was performed using primers against *CREBH* and *BiP*. **(A1,A2)** Representative images of cells transfected with VZV gE **(A1)** or VZV IE62 **(A2)**. (**B1,B2)** RT-PCR values were normalized to *GAPDH* and then differences to values measured for cells that were only treated with transfection reagent alone were computed.](fmicb-05-00322-g0008){#F8}

Discussion {#s4}
==========

We have previously documented that VZV infection induces an autophagic response in infected cells. The basic observation of this report is that VZV infected cells differentially activate the UPR to ER stress as compared to tunicamycin treated cells. The most straightforward explanation for this observation is that tunicamycin treatment produces many misfolded glycoproteins while VZV infection produces an overabundance of normally folded glycoproteins. The elements of the UPR activated in each situation would likely differ. As compared to the positive control of tunicamycin treated cells, VZV infected cells showed increased transcription of a gene associated with decreased cholesterol synthesis as well as increased transcription of the ER stress sensor and transcription factor, *CREBH*. At the same time, VZV infected cells showed decreased transcription of genes associated with ERAD and apoptosis. We hypothesize that this transcriptional profile is compatible with the infected cell attempting to accommodate the influx of viral glycoproteins by greatly increasing the capacity of the ER. For example, increased transcription of *AMFR* (*gp78*) and *INSIG* is associated with a decrease in cholesterol synthesis via degradation of HMG-CoA reductase, an enzyme necessary for cholesterol synthesis (Jo et al., [@B26]; Tsai et al., [@B45]). Decreased cholesterol content would increase the lability of the ER membrane and facilitate expansion of the ER (Mouritsen and Zuckermann, [@B34]).

We also found that some differences in transcription between tunicamycin treated cells vs. VZV infected cells as measured by the UPR specific PCR array could not be confirmed by qPCR, using individual primers selected by our laboratory. The reason behind these discrepancies is unclear but may center around two possibilities: (i) The choice of primers in the PCR array vs. those used in the qPCR measurements or (ii) the asynchronous nature of VZV infection. In general, there was better agreement between tunicamycin treated values as measured by the UPR-specific PCR array and individual qPCR assays. The biggest differences were observed in values measured from VZV infected cells. The latter scenario suggests that asynchronous VZV infection may play a role; for example, the input virus is always extremely low, such that some cells within a monolayer will remain uninfected even at 72 hpi. This same scenario may explain why we have observed similar unexpected differences in experiments to measure protein expression, for example, BiP. Because of increased VZV-induced autophagy, we predicted increased BiP production in infected cells. However, we have observed variable changes in BiP protein expression following VZV infection. Nevertheless, the main conclusions of this report were confirmed by both assays, namely, the significant upregulation of CREBH as well as the more modest upregulation of the cholesterol regulator INSIG.

A key question is whether the infected cell is responding to abundant viral glycoprotein expression through normal mechanisms or alternatively, does the virus encode its own proteins which manipulate the UPR. Recently, Burnett et al found that HSV ICP0 transactivated elements of the UPR and in turn was transactivated by the UPR itself via an ERSE promoter element in the HSV ICP0 gene (Burnett et al., [@B7]). Similarly, both the human and murine strains of the beta herpesvirus cytomegalovirus (CMV) encode proteins that manipulate the UPR---proteins that the VZV genome does not encode (Isler et al., [@B24]; Xuan et al., [@B48]; Qian et al., [@B36]; Stahl et al., [@B41]). VZV does encode a homolog of HSV ICP0---ORF61, but its promoter region does not appear to have any of the known UPR promoter elements: ERSE, ERSE-II, and UPRE based on bioinformatics searches (data not shown). It would be interesting to test VZV ORF61 against a luciferase reporter construct containing the BiP promoter element in future experiments.

In further support of our hypothesis that abundant expression of VZV glycoproteins contributes to the activation of the UPR in a specific way that leads to an enlarged ER and increased autophagosome production, we found that transfection of the VZV gE gene led to increased *CREBH* and *BiP* transcription. We observed abundant VZV gE protein in the ER/Golgi after transfection. In contrast, transfection with VZV IE62, a non-glycosylated viral protein, did not lead to increased transcription of either transcript. Obviously, the IE62 protein never enters the ER/Golgi. These results confirm and expand our 2011 report that transfection with VZV glycoprotein genes resulted in increased ER size and increased autophagosome production. The UPR is known to upregulate autophagy (Yorimitsu et al., [@B50]).

In summary, even though both tunicamycin treatment and VZV infection induced an UPR, the profiles of UPR related genes were different after the two analyses. The UPR in VZV infected cells exhibited greatly increased *CREBH* and cholesterol synthesis regulation transcription and diminished ERAD transcription. The transcription patterns appeared to correlate with increasing ER capacity secondary to increasing viral glycoprotein synthesis in the infected cell. Of importance, the CREBH data were totally unexpected, based on all prior VZV research, and would never have been uncovered in the absence of the UPR array data described in this report.
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